Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Complicated Vascular Anomalies
NCT00975819Phase 2Completed
- Start
- Oct 2009
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in Vascular anomalies, kaposiform hemangioendothelioma (KHE), tufted angioma (TA), Capillary Venous Lymphatic Malformation (CLVM), venous lymphatic malformation (VLM). Started Oct 2009; status: completed.
02
Drugs
sirolimus
03
Conditions
Vascular anomalieskaposiform hemangioendothelioma (KHE)tufted angioma (TA)Capillary Venous Lymphatic Malformation (CLVM)venous lymphatic malformation (VLM)
Beyond the preview
Go deeper on NCT00975819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975819.